Notes
National Health Service
References
1. NICE. NICE recommends new treatment option for adults with obesity and non-diabetic hyperglycaemia who have a high risk of cardiovascular disease. Internet Document : 30 Oct 2020. Available from: URL: https://www.nice.org.uk/news/article/nice-recommends-new-treatment-option-for-adults-with-obesity-and-non-diabetic-hyperglycaemia-who-have-a-high-risk-of-cardiovascular-disease
2. NICE. Skin cancer drug not cost effective for routine NHS use. Internet Document : 5 Nov 2020. Available from: URL: https://www.nice.org.uk/news/article/skin-cancer-drug-not-cost-effective-for-routine-nhs-use
3. NICE recommends new chemotherapy-free treatment option for people with untreated chronic lymphocytic leukaemia. Internet Document : 10 Nov 2020. Available from: URL: https://www.nice.org.uk/news/article/nice-recommends-new-chemotherapy-free-treatment-option-for-people-with-untreated-chronic-lymphocytic-leukaemia
Rights and permissions
About this article
Cite this article
NICE recommends liraglutide & venetoclax + obinutuzumab, but not nivolumab. PharmacoEcon Outcomes News 866, 35 (2020). https://doi.org/10.1007/s40274-020-7295-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7295-2